The International Finance Corporation (IFC) is poised to provide a significant financial boost to Popular Pharmaceuticals PLC, a prominent company based in Bangladesh. The financial package, amounting to approximately $30.7 million, is designed to support the company’s operational needs, specifically targeting the procurement of raw materials essential for its production processes.
Advisory Roles in the Transaction
Renowned law firm TT&A played a pivotal role in advising IFC on this financing transaction. Their dedicated team, led by Managing Partner Gautam Saha, included Partner Nikhil Bahl, Managing Associate Ankita Mandal, and Associate Manasvini Vyas. This collaboration follows TT&A’s recent advisory involvement with IFC in providing loans to companies within the Bangladesh-based PRAN-RFL Group.
Additionally, Farooq and Associates served as the Bangladesh Law counsel for IFC, ensuring that all legal aspects pertaining to the transaction were meticulously addressed.
Utilization of Funds
The proceeds from the loan are earmarked to finance the working capital requirements of Popular Pharmaceuticals. A key focus of the funding is to facilitate the importation of raw materials, a critical component in sustaining the company’s manufacturing operations.
This strategic financial intervention aligns with IFC’s ongoing commitment to fostering economic growth and stability in emerging markets by supporting key industries and businesses.
More Read
Publication Opportunities
If you are interested in having your Deals, Columns, or Press Releases featured on Bar & Bench, you are encouraged to submit the necessary details using the form available here.
